Cannabis
from24/7 Wall St.
20 hours agoCannabis Rescheduling Could Unlock the Biggest MSO Rally Since 2021
Federal cannabis policy is shifting, impacting ETFs focused on US cannabis operators due to rescheduling from Schedule I to Schedule III.
Amplify Seymour Cannabis ETF ( NYSEARCA:CNBS) posted a 17% gain in 2025, but that masks the real story. The fund surged 37% in December alone after President Trump signed an executive order directing Attorney General Pam Bondi to complete rulemaking for reclassifying marijuana from Schedule I to Schedule III under the Controlled Substances Act. Reddit investors have been overwhelmingly bullish, with sentiment scores averaging 82 over the past quarter.